Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Damon Barbacci"'
Autor:
James Z. Deng, Richard R. Rustandi, Damon Barbacci, Andrew R. Swartz, Amanda Gulasarian, John W. Loughney
Publikováno v:
Human Gene Therapy. 33:765-775
Oncolytic virus immunotherapy is emerging as a novel therapeutic approach for cancer treatment. Immunotherapy clinical drug candidate V937 is currently in phase I/II clinical trials and consists of a proprietary formulation of Coxsackievirus A21 (CVA
Autor:
Simon Letarte, Li-Kang Zhang, Douglas D. Richardson, Rong-Sheng Yang, Damon Barbacci, Nick DeGraan-Weber, David R. Bush
Publikováno v:
Journal of Pharmaceutical Sciences. 111:314-322
The commercially available Polysorbate 80 (PS-80) is a highly heterogeneous product. It is a complex and structurally diverse mixture consisting of polymeric species containing polyoxyethylenes (POEs), fatty acid esters, with/or without a carbohydrat
Autor:
M Paul, Chiarelli, Hui-Fang, Chang, Kenneth W, Olsen, Damon, Barbacci, Duane M, Huffer, Bongsup P, Cho
Publikováno v:
Chemical research in toxicology. 16(10)
The product ion formation characteristics of four diastereomeric deoxyadenosine adducts formed by the reaction of the syn and anti diastereomers of trans-3,4-dihydroxy-5,5a-epoxy-3,4,5,5a-tetrahydrobenzo[ghi]fluoranthene are studied by matrix-assiste
Autor:
Jeffrey Seeburger, Adam J. Simon, C Joachim, David Smith, Sethu Sankaranarayanan, Damon Barbacci, Viswanath Devanarayan, David Shera, Wesley Tanaka, Guoxin Wu, Omar Laterza, Dennis Colussi, Mark Shearman, Krista Getty, E. King, Eric A. Price, Guy R. Seabrook
Publikováno v:
Alzheimer's & Dementia. 4:T546-T547
Publikováno v:
Chemical Research in Toxicology. 17:1549-1549
Publikováno v:
Rapid Communications in Mass Spectrometry: RCM; 11/30/2003, Vol. 17 Issue 22, p2517, 6p